Maderer A, Fiteni F, Tanis E, Mauer M, Schmitt T, Aust DE, et al. CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset. AO [Internet]. 2021 Nov. 2 [cited 2024 Sep. 2];60(11):1543-7. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/24028